Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2012 16:55 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2012

NORTHVALE, N.J., June 29, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
June 27, 2012 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year Ending March 31st, 2012 Investor Conference Call on Tuesday, July 3, 2012

NORTHVALE, N.J., June 27, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
June 13, 2012 11:46 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Bridge Loan Facility

NORTHVALE, N.J., June 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has entered into a bridge loan agreement ("Loan") with Jerry Treppel,...
May 22, 2012 09:31 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Issuance of U.S. Patent for Abuse Resistant Oral Dosage Formulation

NORTHVALE, N.J., May 22, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced the issuance of U.S Patent No. 8,182,836 entitled "Abuse-Resistant Oral...
March 22, 2012 16:15 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Signs an Agreement With a Private Hong Kong-Based Company to Develop a Prescription Pharmaceutical Product in the US

NORTHVALE, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that it has entered into an agreement to develop for a...
March 13, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces First Shipment of Generic Hydromorphone Product

NORTHVALE, N.J., March 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of hydromorphone hydrochloride 8 mg tablets, the generic...
February 14, 2012 14:47 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2012

NORTHVALE, N.J., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing generic and branded oral...
February 13, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Discuss Third Quarter 2012 Results of Operations on Wednesday, February 15, 2012

NORTHVALE, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
January 26, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Hydromorphone

NORTHVALE, N.J., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that on January 23, 2012, the U.S. Food and Drug Administration approved the...
January 17, 2012 08:30 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces First Shipment to ThePharmaNetwork

NORTHVALE, N.J., Jan. 17, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that the initial shipment of methadone hydrochloride 10 mg tablets has been made...